…
Anpario plc, together with its subsidiaries, manufactures and distributes natural animal feed additives for animal health, nutrition, and biosecurity. Its health and performance category offers various products that support and maintain animal gut health, including phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; and feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands. The company's hygiene and insect control category contain products comprising water sanitation tablets, 100% natural insect control powders, and natural drying agents that minimizes the environmental microbial burden, supports the gut health, and animal performance under the Credence, Mitex, and Clean & Dry brands; and toxin management category products consisting of mycotoxin binders under the Anpro brand. It has operations in the Americas, Asia, Europe, the Middle East, and Africa. The company was formerly known as Kiotech International plc and changed its name to Anpario plc in November 2011. Anpario plc was founded in 1996 and is headquartered in Worksop, the United Kingdom.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Income before tax | 5.18M | 2.75M | 3.68M | 5.70M | 5.35M |
| Net income | 4.11M | 2.53M | 3.30M | 4.68M | 4.21M |
| Selling general administrative | 12.39M | 11.44M | 10.58M | 10.61M | 10.59M |
| Selling and marketing expenses | - | 1.28M | - | - | - |
| Gross profit | 17.34M | 13.96M | 14.14M | 16.26M | 15.85M |
| Reconciled depreciation | 1.20M | 1.24M | 1.23M | 1.27M | 1.23M |
| Ebit | 5.18M | 2.76M | 3.56M | 5.65M | 5.27M |
| Ebitda | 6.38M | 4.00M | 4.91M | 6.98M | 6.59M |
| Depreciation and amortization | 1.20M | 1.24M | 1.35M | 1.33M | 1.32M |
| Operating income | 4.89M | 2.52M | 3.56M | 5.65M | 5.27M |
| Other operating expenses | 33.30M | 28.48M | 29.54M | 27.72M | 25.25M |
| Interest expense | 0.00M | 0.01M | 0.00M | 0.00M | 0.01M |
| Tax provision | 1.07M | 0.23M | 0.38M | 1.02M | 1.15M |
| Interest income | 0.29M | 0.24M | 0.12M | 0.05M | 0.09M |
| Net interest income | 0.29M | 0.23M | 0.12M | 0.05M | 0.08M |
| Income tax expense | 1.07M | 0.23M | 0.38M | 1.02M | 1.15M |
| Total revenue | 38.20M | 31.00M | 33.10M | 33.37M | 30.52M |
| Total operating expenses | 13.03M | 11.44M | 10.58M | 10.61M | 10.59M |
| Cost of revenue | 20.28M | 17.04M | 18.97M | 17.11M | 14.67M |
| Total other income expense net | 0.29M | 0.23M | 0.12M | 0.05M | 0.08M |
| Net income from continuing ops | 4.11M | 2.53M | 3.30M | 4.68M | 4.21M |
| Net income applicable to common shares | - | - | - | 4.68M | 4.21M |
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Total assets | 47.15M | 40.19M | 48.53M | 47.98M | 44.48M |
| Intangible assets | 5.72M | 4.68M | 5.42M | 5.33M | 5.56M |
| Other current assets | 0.82M | 0.72M | - | 7.42M | 6.38M |
| Total liab | 10.85M | 6.54M | 7.22M | 7.68M | 6.97M |
| Total stockholder equity | 36.29M | 33.65M | 41.31M | 40.30M | 37.51M |
| Deferred long term liab | - | - | - | 0.81M | 0.56M |
| Other current liab | 5.05M | 2.36M | 1.92M | 2.57M | 2.64M |
| Common stock | 4.70M | 4.62M | 5.62M | 5.45M | 5.43M |
| Capital stock | 4.70M | 4.62M | 5.62M | 5.45M | 5.43M |
| Retained earnings | 24.05M | 21.54M | 31.21M | 30.10M | 27.44M |
| Other liab | - | - | - | 2.42M | 1.66M |
| Good will | 6.86M | 5.96M | 5.96M | 5.96M | 5.96M |
| Other assets | - | - | - | 2.27M | 2.19M |
| Cash | 10.50M | 10.54M | 11.74M | 15.54M | 15.82M |
| Total current liabilities | 8.23M | 4.69M | 4.66M | 5.24M | 5.30M |
| Current deferred revenue | - | 0.23M | - | - | - |
| Net debt | -10.43M | -10.46M | -11.69M | -15.46M | -15.73M |
| Short term debt | 0.13M | 0.07M | 0.04M | 0.07M | 0.08M |
| Short long term debt total | 0.07M | 0.08M | 0.05M | 0.09M | 0.09M |
| Other stockholder equity | -5.02M | -3.62M | 4.47M | 4.76M | 4.64M |
| Property plant equipment | - | - | - | 4.68M | 4.23M |
| Total current assets | 27.25M | 24.07M | 31.23M | 30.55M | 27.10M |
| Net tangible assets | - | - | - | 29.81M | 26.54M |
| Short term investments | - | 0.11M | 1.83M | - | - |
| Net receivables | 8.59M | 6.35M | 5.97M | 6.64M | 5.49M |
| Inventory | 7.34M | 6.35M | 9.87M | 7.58M | 4.90M |
| Accounts payable | 3.05M | 2.03M | 2.70M | 2.60M | 2.59M |
| Accumulated other comprehensive income | 3.32M | 3.33M | - | - | -2.45M |
| Common stock total equity | - | - | - | - | 5.43M |
| Treasury stock | - | - | - | - | -1.19M |
| Non currrent assets other | - | 0.48M | 0.15M | 0.11M | 0.64M |
| Non current assets total | 19.90M | 16.13M | 17.30M | 17.44M | 17.38M |
| Capital lease obligations | 0.07M | 0.08M | 0.05M | 0.09M | 0.09M |
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Investments | -4.18M | 1.21M | -1.44M | -1.36M | -1.17M |
| Change to liabilities | - | - | - | 0.38M | 2.23M |
| Total cashflows from investing activities | -4.18M | 1.21M | - | -1.36M | -1.17M |
| Net borrowings | - | - | - | -0.09M | -0.12M |
| Total cash from financing activities | -1.54M | -10.96M | -1.96M | -2.01M | -2.52M |
| Net income | 4.11M | 2.53M | 3.56M | 5.65M | 5.27M |
| Change in cash | -0.04M | -1.20M | -2.00M | -0.28M | 1.98M |
| Begin period cash flow | 10.54M | 11.74M | 13.74M | 15.82M | 13.84M |
| End period cash flow | 10.50M | 10.54M | 11.74M | 15.54M | 15.82M |
| Total cash from operating activities | 5.84M | 8.70M | 1.09M | 3.15M | 5.83M |
| Issuance of capital stock | 1.02M | 0.12M | 0.29M | 0.11M | 0.33M |
| Depreciation | 1.20M | 1.24M | 1.23M | 1.27M | 1.23M |
| Other cashflows from investing activities | 0.29M | 1.49M | - | 0.05M | 0.09M |
| Dividends paid | 1.83M | 1.76M | 2.19M | 2.02M | 1.73M |
| Change to inventory | 0.11M | 3.28M | -1.66M | -2.76M | -1.00M |
| Change to account receivables | -1.90M | 0.16M | - | -0.92M | -0.64M |
| Sale purchase of stock | -0.66M | -9.25M | - | -0.31M | -1.00M |
| Other cashflows from financing activities | -0.66M | -0.01M | -0.07M | -0.09M | -0.12M |
| Change to netincome | - | - | - | 0.49M | -0.20M |
| Capital expenditures | 1.94M | 0.74M | 1.54M | 1.42M | 1.26M |
| Change in working capital | 0.69M | 3.71M | -3.58M | -3.30M | 0.60M |
| Stock based compensation | 0.21M | 0.28M | 0.18M | 0.04M | 0.05M |
| Other non cash items | -0.16M | 0.94M | -0.30M | -0.52M | -1.31M |
| Free cash flow | 4.20M | 7.95M | -0.45M | 1.72M | 4.57M |
Sector: Consumer Defensive Industry: Packaged Foods
|
Stock Name
|
Change
(GBX) |
Price
(GBX) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| ANP Anpario Plc |
- -% |
525.00 | 12.11 | 10.93 | 1.65 | 1.90 | 1.39 | 6.97 |
| ABF Associated British Foods PLC |
-39.00 1.98% |
1927.00 | 13.37 | 12.18 | 0.69 | 1.21 | 0.82 | 6.04 |
| KYGA Kerry Group |
-0.80 0.82% |
97.00 | 0.17 | 13.30 | 1.60 | 1.85 | 1.94 | 11.32 |
| MICC The Magnum Ice Cream Company N.V. |
-1.00 0.07% |
1449.00 | 25.07 | 13.30 | 0.82 | 12.11 | 1.31 | 11.19 |
| GLB Glanbia plc |
-0.80 3.85% |
20.00 | 0.28 | 12.38 | 1.08 | 2.44 | 1.36 | 13.84 |
Anpario plc, together with its subsidiaries, manufactures and distributes natural animal feed additives for animal health, nutrition, and biosecurity. Its health and performance category offers various products that support and maintain animal gut health, including phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; and feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands. The company's hygiene and insect control category contain products comprising water sanitation tablets, 100% natural insect control powders, and natural drying agents that minimizes the environmental microbial burden, supports the gut health, and animal performance under the Credence, Mitex, and Clean & Dry brands; and toxin management category products consisting of mycotoxin binders under the Anpro brand. It has operations in the Americas, Asia, Europe, the Middle East, and Africa. The company was formerly known as Kiotech International plc and changed its name to Anpario plc in November 2011. Anpario plc was founded in 1996 and is headquartered in Worksop, the United Kingdom.
Manton Wood Enterprise Park, Worksop, United Kingdom, S80 2RS
44 19 0953 7380
157
| Name | Title | Year Born |
|---|---|---|
| Mr. Richard P. Edwards B.E., M.B.A., B Eng (Hons), C Eng, MBA | Exec. Vice Chairman & CEO | 1965 |
| Mr. Marc Charles Wilson A.C.M.A., B.A. | Group Fin. Director & Director | 1988 |
| Ms. Karen L. Prior B.Sc., B.Sc. (Hons), F.C.A. | Corp. Responsibility Director, Company Sec. & Director | 1960 |
| Mr. Shane Bailey | Operations Director | NA |
| Dr. Wendy Wakeman | Group Technical Director | NA |
| Ms. Lynne Moss | Legal & Fin. Mang. | NA |
| Ms. Pam McLaren | Bus. Director of Sales | NA |
| Ms. Pippa Pang | Marketing Director | NA |
| Ms. Sarah Osborne BSc. Hons | Corp. Devel. Director | NA |
| Mr. John Butlin | Group Financial Controller | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.